Gene · 7357
Papers2,116
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,116
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fused Pyrazole Urea Analogs as Glucosylceramide Synthase Inhibitors for Treating Diseases. | ACS Med Chem Lett | 2023 | 37583817 | PubTator, text mining | PubMed |
| A Sphingolipidomic Profiling Approach for Comparing X-ray-Exposed and Unexposed HepG2 Cells. | Int J Mol Sci | 2023 | 37569739 | PubTator, text mining | PubMed |
| Brain-specific glycosylation enzyme GnT-IX maintains levels of protein tyrosine phosphatase receptor PTPRZ, thereby mediating glioma growth. | J Biol Chem | 2023 | 37543361 | PubTator, text mining | PubMed |
| The expanding organelle lipidomes: current knowledge and challenges. | Cell Mol Life Sci | 2023 | 37530856 | PubTator, text mining | PubMed |
| Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease. | Pharmaceutics | 2023 | 37514122 | PubTator, text mining | PubMed |
| Mass Spectrometry Detects Sphingolipid Metabolites for Discovery of New Strategy for Cancer Therapy from the Aspect of Programmed Cell Death. | Metabolites | 2023 | 37512574 | PubTator, text mining | PubMed |
| HIV and SIV Envelope Glycoproteins Interact with Glycolipids and Lipids. | Int J Mol Sci | 2023 | 37511488 | PubTator, text mining | PubMed |
| Rectal Cancer Tissue Lipidome Differs According to Response to Neoadjuvant Therapy. | Int J Mol Sci | 2023 | 37511236 | PubTator, text mining | PubMed |
| Lactate Can Modulate the Antineoplastic Effects of Doxorubicin and Relieve the Drug's Oxidative Damage on Cardiomyocytes. | Cancers (Basel) | 2023 | 37509389 | PubTator, text mining | PubMed |
| Increased hepatic Akt phosphorylation alleviated glucose intolerance and improved liver function in leptin-deficient mice. | Clin Exp Hepatol | 2023 | 37502436 | PubTator, text mining | PubMed |
| Identification of potential classes of glycoligands mediating dynamic endothelial adhesion of human tumor cells. | Glycobiology | 2023 | 37486674 | PubTator, text mining | PubMed |
| Effects of miglustat therapy on neurological disorder and survival in early-infantile Niemann-Pick disease type C: a national French retrospective study. | Orphanet J Rare Dis | 2023 | 37480097 | PubTator, text mining | PubMed |
| Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial. | Lancet Neurol | 2023 | 37479372 | PubTator, text mining | PubMed |
| Novel Mutation in the Feline NPC2 Gene in Cats with Niemann-Pick Disease. | Animals (Basel) | 2023 | 37458497 | PubTator, text mining | PubMed |
| Exploring the Pathophysiologic Cascade Leading to Osteoclastogenic Activation in Gaucher Disease Monocytes Generated via CRISPR/Cas9 Technology. | Int J Mol Sci | 2023 | 37446383 | PubTator, text mining | PubMed |
| Engineering RNA export for measurement and manipulation of living cells. | Cell | 2023 | 37437570 | PubTator, text mining | PubMed |
| Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I-III lung adenocarcinoma. | Genes Dis | 2023 | 37397559 | PubTator, text mining | PubMed |
| Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches. | Genes Dis | 2023 | 37396535 | PubTator, text mining | PubMed |
| Novel Therapeutic Approaches in Inherited Neuropathies: A Systematic Review. | Pharmaceutics | 2023 | 37376074 | PubTator, text mining | PubMed |
| Glucosylceramide Synthase Inhibitors Induce Ceramide Accumulation and Sensitize H3K27 Mutant Diffuse Midline Glioma to Irradiation. | Int J Mol Sci | 2023 | 37373053 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7357/papers?page=9